[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340443-105":59,"doc-detail-340443-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-horizon-of-thyroid-imaging-reporting-and-data-system-in-the-diagnostic-performance-of-thyroid-nodules-clinical-application-and-future-perspectives","The Horizon of Thyroid Imaging Reporting and Data System in the Diagnostic Performance of Thyroid Nodules - Clinical Application and Future Perspectives","","Thyroid nodules are common and often progress slowly, leading to the development of the Thyroid Imaging Reporting and Data System (TI-RADS) to reduce unnecessary biopsies of non-cancerous lesions and to standardize risk stratification. TI-RADS provides a numeric scoring approach based on ultrasound features, grouping nodules by cumulative score to estimate benign versus malignant likelihood. Multiple TI-RADS versions are reviewed regarding diagnostic performance, shared principles, differences, and potential future developments.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-horizon-of-thyroid-imaging-reporting-and-data-system-in-the-diagnostic-performance-of-thyroid-nodules-clinical-application-and-future-perspectives/340443/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-horizon-of-thyroid-imaging-reporting-and-data-system-in-the-diagnostic-performance-of-thyroid-nodules-clinical-application-and-future-perspectives/340443.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does TI-RADS aim to solve in thyroid nodule evaluation?","Question",{"text":113,"@type":114},"TI-RADS was developed to minimize unnecessary biopsies of non-cancerous nodules and to improve diagnostic precision using a uniform risk-stratification framework that communicates when biopsy is needed.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does TI-RADS estimate malignancy risk?",{"text":118,"@type":114},"TI-RADS uses a numerical scoring system derived from ultrasound characteristics. The total score determines the category that reflects the likelihood of a thyroid nodule being benign or malignant.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is ultrasound considered a key first-line modality for thyroid nodules?",{"text":122,"@type":114},"Diagnostic ultrasound is widely accepted as the first-line approach for assessing thyroid nodules and supports detection, discrimination between malignant and benign features, and guidance for fine-needle aspiration.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340443,1790196481,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","The Horizon of Thyroid Imaging Reporting and Data System in the Diagnostic Performance of Thyroid Nodules: Clinical Application and  \nFuture Perspectives  \nSeyedeh Niloofar Sharafi,1 Mohammad Moarefzadeh2 and Milad Tari Moradi3  \n1. Nottingham University Hospital NHS Trust, Nottingham, UK; 2. Lorestan University of Medical Sciences, Lorestan, Iran; 3. Qazvin University of Medical Sciences, Qazvin, Iran  \nDOI: [https://doi.org/10.17925/EE.2024.20.2.11](https://doi.org/10.17925/EE.2024.20.2.11)  \nThe widespread occurrence of thyroid nodules and the typically slow progression of thyroid cancer have led to the development of the  \nthyroid imaging reporting and data system (TI-RADS) . The primary objectives behind the development of TI-RADS were to minimize  \nunnecessary biopsies of non-cancerous nodules, enhance the overall precision of diagnosis and establish a uniform risk-stratification framework based on the lexicon to notify healthcare professionals of nodules that require a biopsy. The identification and precise diagnosis of thyroid nodules have led to improved clinical practice examination reports within the general population. TI-RADS is a risk-stratification system related to thyroid lesions and based on ultrasound characteristics and is similar to the structure of the breast imaging reporting and data system. There are various versions of TI-RADS, with some being widely used and adequately validated, while others lacking thorough evaluation. TI-RADS uses a numerical scoring system for characteristics, and its categories are determined by the cumulative score of a thyroid nodule, indicating the likelihood of it being benign or malignant. In this article, the various TI-RADS systems were examined as a successful method for producing precise and comprehensive documentation, with a particular emphasis on their functionality, similarities, distinctions and potential future developments.  \nKeywords  \nClassification, diagnostic imaging, risk assessment, thyroid cancer, thyroid nodule, ultrasonography  \nDisclosures: Seyedeh Niloofar Sharafi, Mohammad Moarefzadeh, and Milad Tari Moradi have no financial or non-financial relationships or activities to declare in relation to this article.  \nReview Process: Double-blind peer review.  \nCompliance with ethics: This article involves a review of the literature and did not involve any studies with human or animal subjects performed by any of the authors.  \nData availability: Data sharing is not applicable to this article as no datasets were generated or analysed during the writing of this article.  \nAuthorship: All named authors meet the criteria of the International Committee of Medical Journal Editors for authorship for this manuscript, take responsibility for the integrity of the work as a whole and have given final approval for the version to be published.  \nAccess: This article is freely accessible at [touchENDOCRINOLOGY.com](touchENDOCRINOLOGY.com) © Touch Medical Media 2024.  \nReceived: 24 December 2023  \nAccepted: 20 February 2024  \nPublished online: 12 July 2024  \nCitation: touchREVIEWS in Endocrinology. 2024;20(2):81– 90  \nCorresponding author: Dr Mohammad Moarefzadeh, School of Medicine, Kamalvand University Campus, Lorestan University of Medical Sciences, KhorramabadBorujerd Road, Khorramabad, Lorestan, Iran.  \nE: mohammad. moarefzadeh. md@gmail.com  \nSupport: No funding was received in the publication of this article.  \nThyroid nodules are common worldwide, and their prevalence is increasing. Most nodules areasymptomatic and detected incidentally on cross-sectional imaging or physical examination. In rare cases (10–15%), nodules are malignant and require diagnostic evaluation. Even malignant nodules frequently show non-aggressive behaviour.1 The increase in the incidence of thyroid cancer is unfairly distributed globally, and the morbidity increases moderately from year to year, mainly in female patients.2 Moreover, the prevalence of thyroid nodules increases with increasing","cbCaim0UUYfEFJMs","https://ap.wps.com/l/cbCaim0UUYfEFJMs","pdf",559399,"English","# Introduction\n## TI-RADS objectives and rationale\n# TI-RADS structure and scoring\n## Ultrasound-based risk stratification\n## Versions and validation status\n# Clinical context: thyroid cancer and nodules\n## Prevalence and detection\n## Imaging and fine-needle aspiration\n# Future perspectives\n## Potential developments","[{\"question\":\"What problem does TI-RADS aim to solve in thyroid nodule evaluation?\",\"answer\":\"TI-RADS was developed to minimize unnecessary biopsies of non-cancerous nodules and to improve diagnostic precision using a uniform risk-stratification framework that communicates when biopsy is needed.\"},{\"question\":\"How does TI-RADS estimate malignancy risk?\",\"answer\":\"TI-RADS uses a numerical scoring system derived from ultrasound characteristics. The total score determines the category that reflects the likelihood of a thyroid nodule being benign or malignant.\"},{\"question\":\"Why is ultrasound considered a key first-line modality for thyroid nodules?\",\"answer\":\"Diagnostic ultrasound is widely accepted as the first-line approach for assessing thyroid nodules and supports detection, discrimination between malignant and benign features, and guidance for fine-needle aspiration.\"}]","The Horizon of Thyroid Imaging Reporting and Data System in the Diagnostic Performance of Thyroid Nodules - Clinical Application and Future Perspectives | PDF",1790036532,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a58c6d2a7d1fe5c399e17474f69f70ac.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67ec03641f3d0f092f1707fab4e9825c.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6aec11c5dd9e0421335ae68eecdb63a8.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/213ef747baaa266ed6e0ba44e2f0271d.webp",980,1385]